Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer

2016143 citationsJournal Articlebronze Open Access

Authors

clinicaltrials.gov Identifier: NCT02472964; EudraCT Identifier: 2011-001965-42.

Good health and well-being

Published in: JAMA

Volume 317, Issue 1, pp. 37-37

Field-Weighted Citation Impact: 11.04